Test your knowledge with BlueDil !

What does the National Plan for Rare Diseases 3 (2018 to 2022) provide for its financing? Is it comparable to the NRP2 funding?

The total funding of PNMR3 is €777M over 5 years, i.e. approximately €155M allocated per year.
In 2015, according to the DGOS, health institutions and rare disease health sectors have been financed to a total of €144.5M (€128.9M ONDAM to health institutions treating rare diseases [excluding rare cancers] + €15.6M MIG from rare disease health sectors).
NMRP2 did not detail the funding by strategic axis. NMRP3 introduces this detail.

For more information go to => https://solidarites-sante.gouv.fr/IMG/pdf/plan_national_maladies_rares_2018-2022.pdf